Table 3.
The top 12 enriched GO terms for DSGs.
| GO-BP Term | pvalue | qvalue | gene |
|---|---|---|---|
| dopamine receptor signaling pathway | 2.38E-06 | 0.001887 | PALM/GNA15/GNA11/KLF16 |
| skeletal muscle contraction | 0.000127 | 0.032678 | EEF2/TCAP/MYH8 |
| multicellular organismal movement | 0.000239 | 0.032678 | EEF2/TCAP/MYH8 |
| musculoskeletal movement | 0.000239 | 0.032678 | EEF2/TCAP/MYH8 |
| trabecula morphogenesis | 0.000255 | 0.032678 | MED1/SBNO2/UBE4B |
| DNA-templated transcription, initiation | 0.000289 | 0.032678 | MED1/MED16/POLR2E |
| MED24/POLRMT | |||
| phospholipase C-activating dopamine receptor signaling pathway | 0.000289 | 0.032678 | GNA15/GNA11 |
| natural killer cell chemotaxis | 0.000352 | 0.03489 | CCL7/CCL4 |
| negative regulation of keratinocyte proliferation | 0.000498 | 0.038042 | MED1/KDF1 |
| androgen receptor signaling pathway | 0.000544 | 0.038042 | MED1/MED16/MED24 |
| cardiac muscle tissue morphogenesis | 0.000544 | 0.038042 | MED1/TCAP/UBE4B |
| response to radiation | 0.000691 | 0.038042 | PPP1R1B/CCL7/GNA11/MYCECT2/UBE4B |